Extrapyramidal Disturbances Caused by Inappropriate Prescribing
BMJ 295:30-31, Pall,H.S.&Williams,A.C., 1987
Flunarizine- & -Cinnarizine-Induced Extrapyramidal Reactions
Neurol 37:881-884, Micheli,F.,et al, 1987
Aggravation of Parkinson's Disease by Cinnarizine
JNNP 50:804-805, Marti-Masso,J.F.,et al, 1987
Neurological Clues from Environmental Neurotoxins
BMJ 295:346-347, Martyn,C.N., 1987
Factors that Influence the Occurrence of Response Variations in Parkinson's Disease
Ann Neurol 22:4-7, deJong,G.J.,et al, 1987
Multi-Center Study of Parkinson Mortality with Early Versus Later Dopa Treatment
Ann Neurol 22:8-12, Diamond,S.G.,et al, 1987
Adjuvant Therapy of Parkinsonian Tremor
Arch Neurol 44:921-923, Koller,W.C.&Herbster,G., 1987
Neuropsychological Disturbances in Hemiparkinson's Disease
Neurol 37:1762-1764, Starkstein,S.,et al, 1987
Parkinson's Disease:Sensory & Motor Problems in Arms & Hands
Neurol 37:951-956, Schneider,J.S.,et al, 1987
Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987
Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987
Forms of Dystonia in Patients with Parkinson's Disease
Neurol 37:1009-1011, Kidron,D.&Melamed,E., 1987
Clinical & Biochemical Correlates of Bradyphrenia in Parkinson's Disease
Neurol 37:1130-1134, Mayeux,R.,et al, 1987
Neuropathologic & Clinical Features of Parkinson's Disease in Alzheimer's Disease Patients
Neurol 37:754-760, Ditter,S.M.&Mirra,S.S., 1987
Adrenal Grafts for Parkinson's Disease
Letter, NEJM 317:1091-10931987., , 1987
Transplantation in Parkinson's Disease:Two Cases of Adrenal Medullary Grafts to the Putamen
Ann Neurol 22:457-468, Lindvall,O.,et al, 1987
Neural Transplants:Are We Ready
Ann Neurol 22:455-456, Joynt,R.J.&Gash,D.M., 1987
Management of Parkinson's Disease
BMJ 294:1393-1396, Gibberd,F.B., 1987
Parkinson's Disease & Motor Fluctuations:Long-Acting Carbidopa. Levodopa (CR-4-Sinemet)
Neurol 37:875-878, Goetz,C.G.,et al, 1987
Controlled-Release Levodopa/Carbidopa. II. Sinemet CR4 Treatment of Response Fluctuations in Parkinson's Disease
Neurol 37:1607-1612, Cedarbaum,J.M.,et al, 1987
Controlled Release Levodopa-Carbidopa (CR-5) in the Management of Parkinsonian Motor Fluctuations
Arch Neurol 44:1010-1012, Juncos,J.L.,et al, 1987
Dietary Influence on the Antiparkinsonian Response to Levodopa
Arch Neurol 44:1003-1005, Juncos,J.L.,et al, 1987
Plasma Levels of Amino Acids Correlate with Motor Fluctuations in Parkinsonism
Arch Neurol 44:1006-1009, Pincus,J.H.&Barry,K.M., 1987
Dietary Therapy for Motor Fluctuations in Parkinson's Disease
Arch Neurol 44:1119-1121, Kurlan,R., 1987
Pathophysiol Clin Assess of Motor Symptoms in PD, Jankovic in Handbook of Parkinson's Disease, Ed W. C. Koller
New York 1987, p. 118-120, 475-488., Marcel Dekker,Inc., 1987
Parkinson's Disease & Myasthenia Gravis:Adverse Effect of Trihexyphenidyl on Neuromuscular Transmission
Neurol 37:832-833, Ueno,S.,et al, 1987
Parkinson's Disease & Pregnancy
Neurol 37:1245-1249, Golbe,L.I., 1987
Parkinson's Disease & Megacolon:Concentric Hyaline Inclusions (Lewy Bodies) in Enteric Ganglion Cells
Neurol 37:1253-1255, Kupsky,W.J.,et al, 1987
Levodopa Methyl Ester Treatment of Parkinson's Disease
Neurol 37:1242-1245, Juncos,J.L.,et al, 1987
Raised Cerebrospinal-Fluid Copper Concentration in Parkinson's Disease
Lancet 2:238-241, Pall,H.E.,et al, 1987
Giant Middle Cerebral Aneurysm Presenting as Hemiparkinsonism
JNNP 50:1075, Gross,M., 1987
Progressive Supranuclear Palsy & a Multi-Infarct State
Neurol 37:570-576, Dubinsky,R.M.&Jankovic,J., 1987
Caffeine & Tremor
Neurol 37:169-172, Koller,W.,et al, 1987
Neurologic Aspects of Boxing
Arch Neurol 44:453-459, Jordan,B.D., 1987
Movement Disorders & AIDS
Neurol 37:37-41, Nath,A.,et al, 1987
Calcium Channels & Calcium Channel Antagonists
Ann Neurol 21:317-330, Greenberg,D.A., 1987
A Case of Normal Pressure Hydrocephalus Presenting as Levodopa Responsive Parkinsonism
JNNP 50:234, Clough,C.G., 1987
Pathophysiology & Clinical Assessment of Motor Symptoms in Parkinson's Disease
In Handbk of Parkinson's Disease, Marcel Dekker, Inc, New York, p997., Jankovic,J., 1987
Pleuropulmonary & Retroperitoneal Fibrosis Associated with Bromocriptine Treatment
JNNP 50:1706-1707, Ward,C.D.,et al, 1987
Classification of Parkinsonism
in Handbook of Parkinson's Disease, Marcel Dekker, Inc, New York, Ch 3, p 61., Koller,W.C., 1987
The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986
Neuropeptides in Neurological Disease
Ann Neurol 20:547-565, Beal,M.F.&Martin,J.B., 1986
Alzheimer's Disease, Parkinson's Disease, & Motoneurone Disease:Abiotropic Interaction Between Ageing & Environment
Lancet 2:1067-1068, Calne,D.B.,et al, 1986
Metoclopramide-Induced Parkinsonism in Hemodialysis Patients
Arch Int Med 146:2070-2071, Sirota,R.A.,et al, 1986
Locus Ceruleus Lesions & Eosinophilic Inclusions in MPTP-Treated Monkeys
Ann Neurol 20:449-455, Forno,L.S.,et al, 1986
Clinicopath. Conference
Pick's Disease of Brain, with Frontal Lobar Atrophy, Degen of Basal Ganglia, Case 16-1986, NEJM 314:, 101-,1986., 1986
The Clinical Features & Natural History of the Steele-Richardson-Olszewski Syndrome (Prog Supranuclear Palsy)
Neurol 36:1005-1006, Maher,E.R.,et al, 1986
Akathisia-Or not Sitting
BMJ 292:1034-1035, Szabadi,E., 1986
MPTP:A Neurotoxin Relevant to the Pathophysiology of Parkinson's Disease, The 1985 George Cotzias Lecture
Neurol 36:250-258, Snyder,S.H.&D'Amato,R.J., 1986
Parkinsonism, Tardive Dyskinesia, Akathisia, & Depression Induced by Flunarizine
Lancet 1:1303-1304, Chouza,C.,et al, 1986